A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
Clinical trial NCT07208058 · RECRUITING
Trial details
- NCT number
- NCT07208058
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-21
- Primary completion
- 2026-12-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.